Washington, D.C. 20549






Report of Foreign Private Issuer

Pursuant to Rule 13a-16 or 15d-16 under

the Securities Exchange Act of 1934

For the month of June, 2022

Commission File Number 001-39670




(Translation of registrant’s name into English)



6 Tide Street, Suite 400

Boston, Massachusetts 02210

(Address of principal executive office)



Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.

Form 20-F  ☒                Form 40-F  ☐

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1):  ☐

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7):  ☐





On May 9, 2022, PureTech Health plc (LSE: PRTC, Nasdaq: PRTC) (the “Company”) announced the commencement of a $50 million share repurchase program (the “Program”) of its ordinary shares of one pence each (“Ordinary Shares”). The Company plans to execute the Program in two equal tranches. In respect of the first tranche, PureTech entered into an irrevocable non-discretionary instruction with Jefferies International Limited (“Jefferies”) in relation to the purchase by Jefferies of Ordinary Shares for an aggregate consideration (excluding expenses) of no greater than $25 million and the simultaneous on-sale of such Ordinary Shares by Jefferies to PureTech. Jefferies makes its trading decisions in relation to the Ordinary Shares independently of, and uninfluenced by, the Company. Purchases may continue during any close period to which the Company is subject. Any purchase of Ordinary Shares under the first tranche of the Program are carried out on the London Stock Exchange and any other UK recognized investment exchange which may be agreed, in accordance with pre-set parameters and in accordance with, and subject to limits, including those limits related to daily volume and price, prescribed by the Company’s general authority to repurchase Ordinary Shares granted by its shareholders at its most recent annual general meeting on May 27, 2021, Chapter 12 of the Financial Conduct Authority’s UK Listing Rules, Article 5(1) of Regulation (EU) No. 596/2014 (as incorporated into UK domestic law by the European Union (Withdrawal) Act 2018) and Commission Delegated Regulation (EU) 2016/1052 (as incorporated into UK domestic law by the European Union (Withdrawal) Act 2018). All Ordinary Shares repurchased under the Program will be held in treasury.

During the month ended June 30, 2022, the Company had the following daily purchases of its own Ordinary Shares under the Program through Jefferies:



   Ordinary Shares
     Volume Weighted
Average Price Paid
per Ordinary Share
     Highest Price Paid      Lowest Price Paid  

June 1, 2022

     50,156        179.20p        181.00p        175.20p  

June 6, 2022

     46,779        181.60p        187.00p        177.40p  

June 7, 2022

     46,350        175.99p        180.40p        173.00p  

June 8, 2022

     44,526        181.47p        185.80p        175.60p  

June 9, 2022

     46,602        181.14p        184.20p        178.20p  

June 10, 2022

     46,606        173.05p        178.40p        169.80p  

June 13, 2022

     50,508        163.77p        166.00p        161.00p  

June 14, 2022

     56,309        159.90p        164.20p        155.80p  

June 15, 2022

     58,827        157.18p        159.20p        155.60p  

June 16, 2022

     61,103        153.34p        157.20p        150.00p  

June 17, 2022

     65,330        156.03p        160.40p        150.00p  

June 20, 2022

     43,188        157.13p        163.00p        149.40p  

June 21, 2022

     35,858        162.79p        162.80p        162.20p  

June 22, 2022

     108,930        159.72p        164.00p        156.60p  

June 23, 2022

     120,037        161.35p        163.80p        159.00p  

June 24, 2022

     79,353        166.16p        166.60p        164.40p  

June 27, 2022

     30,770        170.25p        170.40p        166.00p  

June 28, 2022

     3,432        171.60p        171.60p        171.60p  

June 29, 2022

     131,279        168.16p        171.40p        165.20p  

June 30, 2022

     141,210        170.72p        173.80p        167.20p  

During the month ended June 30, 2022, the Company repurchased an aggregate of 1,267,153 Ordinary Shares. As of June 30, 2022, the Company’s issued share capital was 288,611,120 shares, 2,010,269 of which were held in treasury, resulting in total voting rights in the Company of 286,600,851 shares. To view the details of the individual transactions, please paste the following URL(s) into the address bar of your browser with respect to each individual date of repurchase under the Program:

June 1, 2022: https://data.fca.org.uk/artefacts/NSM/RNS/4394137.html

June 6, 2022: https://data.fca.org.uk/artefacts/NSM/RNS/4394394.html

June 7, 2022: https://data.fca.org.uk/artefacts/NSM/RNS/4395829.html

June 8, 2022: https://data.fca.org.uk/artefacts/NSM/RNS/4397643.html

June 9, 2022: https://data.fca.org.uk/artefacts/NSM/RNS/4399229.html

June 10, 2022: https://data.fca.org.uk/artefacts/NSM/RNS/4400772.html

June 13, 2022: https://data.fca.org.uk/artefacts/NSM/RNS/4402580.html

June 14, 2022: https://data.fca.org.uk/artefacts/NSM/RNS/4404024.html

June 15, 2022: https://data.fca.org.uk/artefacts/NSM/RNS/4405896.html

June 16, 2022: https://data.fca.org.uk/artefacts/NSM/RNS/4407371.html

June 17, 2022: https://data.fca.org.uk/artefacts/NSM/RNS/4409107.html

June 20, 2022: https://data.fca.org.uk/artefacts/NSM/RNS/4410787.html

June 21, 2022: https://data.fca.org.uk/artefacts/NSM/RNS/4412925.html

June 22, 2022: https://data.fca.org.uk/artefacts/NSM/RNS/4414074.html

June 23, 2022: https://data.fca.org.uk/artefacts/NSM/RNS/4415721.html

June 24, 2022: https://data.fca.org.uk/artefacts/NSM/RNS/4417224.html

June 27, 2022: https://data.fca.org.uk/artefacts/NSM/RNS/4418886.html

June 28, 2022: https://data.fca.org.uk/artefacts/NSM/RNS/4420771.html

June 29, 2022: https://data.fca.org.uk/artefacts/NSM/RNS/4422525.html

June 30, 2022: https://data.fca.org.uk/artefacts/NSM/RNS/4424516.html


Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.




Date: July 5, 2022




/s/ Daphne Zohar




Daphne Zohar




Chief Executive Officer